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Abstract 
 
During the radiation therapy (RT) process, the treatment is planned and simulated 
with a treatment planning system (TPS): the organs at risk (OAR) and the tumor 
target are identified and contoured, and the RT dose, delivered by the  planned 
photon beams, is obtained for optimization of the resulting plan. The contouring 
work-up of tumor target identifies the Planning Treatment Volume (PTV), i.e. the 
physical RT treatment volume. PTV of glioblastomas (GB) includes, after expansion, 
Gross Tumor Volume (GTV, the tumor) and Clinical Target Volume (CTV, tumor plus 
edema). Usually, GTV contouring is performed manually. In this work, we used 
GlioCAD, a Computer-Assisted Detection software for automatic contouring of 
gliomas in MRI/DTI, to delineate GTV. The dataset included the images of 21 
patients undergoing RT for GB. For each patient, we co-registered CT-planning 
images and diagnostic MRI (16 T1-gad, 6 T2 Flair, 13 Flair Fat Sat), which were used 
for GlioCAD training and validation. CAD outlined the tumor with good accuracy, 
after ruling out some false positives in post-processing. We identified GTVs, suitable 
for RT requirements. An evolution of GlioCAD will take into account edema for 
outlining CTV. The method seems promising. A further automatic system for the 
delineation of sites at risk in the brain is under development, which may be helpful 
for standardization of RT-treatment planning. 
 
 
Introduction 
The gold standard treatment for malignant 
gliomas consists of surgical intervention 
followed by radiotherapy and chemotherapy 
[1]. The contouring process in radiotherapy 
(RT) of malignant gliomas consists in the 
identification of two volumes: the 
macroscopically appreciable tumor (GTV, 
Gross Tumor Volume) and a region (edema) of 
likely infiltration (CTV, Clinical Target Volume), 
Fig. 1. A further margin is added to CTV to 
create the PTV (Planning Target Volume), 
which takes into account the possible 
positioning errors during treatment. The CTV 
can be targeted with a boost irradiation, with 
respect to the reference RT dose delivered to 
CTV/PTV. 
Both planning CT and diagnostic MR images 
are used to improve contouring reliability. 
 97 
 
The definition of treatment volumes in GB 
differs in subsequent, various cooperative 
group trials by EORTC (Organization for 
Research and Treatment of Cancer) and RTOG 
(Radiation Therapy Oncology Group), with 
some differences in margins (regarding, e.g.: 
GTV, inclusion of peritumoral edema, etc. 
[1,2,3]), and a definitive consensus has not yet 
been reached. Moreover, heterogeneity 
between operators may occur, due to 
experience and image interpretation [4]. In 
this perspective, a reproducible and efficient 
method for delineating the tumor volumes for 
RT is advisable. 
 
 
Figure 1. Diagram of the main irradiation volumes (from 
ICRU 50). 
 
 
It has been demonstrated that MRI is more 
sensitive than CT in lesion detection and 
glioma margin delineation  [5], which makes 
MRI more appropriate for (semi)automatic GB 
contouring and GTV/CTV delineation. 
In this preliminary work, GlioCAD [6], a CAD 
(Computer-Assisted Detection) software 
system for cerebral glioma segmentation in 
MRI/DTI, was used to delineate the GTV 
treatment volumes in GB patients, in order to 
get operator-independent semi-automatic 
contouring. GlioCAD application was 
preceded and followed by data processing 
steps whose purpose was to match the data 
with the software, and to make the 
automatically-contoured volumes compliant 
with the radiotherapy requirements.  
Materials and methods 
The dataset consisted of the images of 21 
patients treated for GB at the Radiotherapy 
Unit of Siena (Italy). For each patient we 
obtained planning CT images and diagnostic 
MRI. MR images (16 T1-gad, 6 T2 Flair, 13 Flair 
Fat Sat scans) were achieved for a better 
identification of the macroscopic tumor 
region (GTV) and the surrounding edema 
(CTV). The images, after the manual 
contouring of the treatment volumes and 
organs at risk (OAR), were used to train 
GlioCAD, a CAD system for automatic 
segmentation of cerebral gliomas in MRI and 
DTI (Diffusion-Tensor Imaging). 
The manual contouring procedure included 
the following steps: 
1. Manual segmentation and contouring 
of T1-gad images identifying the 
macroscopic tumor volume (GTV), that 
is, the area of contrast enhancement; 
or, in post-surgical patients, the 
surgical cavity including any contrast-
enhanced surrounding area. 
2. A margin of at least 2 cm was added 
isotropically to the GTV to obtain the 
CTV, extended if necessary to include 
perilesional edema as evident in FLAIR 
images, with manual adjustments. 
Manual correction was also performed 
if the expansion resulted in a volume 
extending beyond natural anatomical 
barriers (e.g. bone structures, falx, 
ventricular system). 
3. A further 0.5-cm margin was added to 
CTV to create PTV. 
The application of GlioCAD to the automatic 
GTV contouring (Figs. 2 and 3) is described 
hereafter, and is based on the combined use 
of T1-gad images and FLAIR images, all of 
them co-registered with the CT scans. 
GlioCAD [6] is a supervised system, thus it 
requires an initial set of images where the 
desired GTV has already been delineated by 
the physicians. GlioCAD  is based on the 
calculation of texture features (derived from 
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Figure 2 The shape of the treatment volume from two techniques of radiotherapy planning. On the left is
a cuboidal shape based on old-fashioned ‘square’ planning from orthogonal radiographs; on the right is a
spherical shape produced from conformal planning. The two volumesare designed to treat the same tumour
target, but thesphere ishalf thevolumeof thecube.
Figure3 Diagram to illustrate themain radiotherapy planning volumes, taken from ICRU Report 50.
Specific target volumes for radiotherapy
planning
There are three main volumes to be considered in
radiotherapy planning, though only the first two of these
volumes are of real interest to diagnostic colleagues
(see Fig. 3). The first of these two volumes is the
position and extent of the primary tumour; this is
known as the gross tum ur volu e (GTV). The second
volume surrounds the GTV and describes the extent of
microscopic, un-imageable tumour spread; this is known
as the clinical target volume (CTV). Once these two
volumes are established, the third volume, the planning
target volume (PTV), which allows for uncertainties in
planning or delivery, must be added, and the normal tissue
structures in the vicinity of the target must be considered.
The original concepts of the GTV and CTV were
detailed in Report 50 from The International Commission
of Radiation Units and Protection (ICRU) in 1993 [6].
The report also described the principle of the margin
needed for uncertainty in the process of planning and
delivery, i.e. the PTV. The concept of the PTV was
refined in ICRU Report 62 in 1999 [7], and this added
further information about organs at risk (ORs) and the
need, in certain specific circumstances, to add a margin
for uncertainty around an OR to produce a planning
organ at risk volume (PRV). Interestingly, Report 62 was
specifically triggered by the increasing availability of
conformal radiotherapy, where margins are more critical,
and the need to describe normal tissue doses in more
detail. These two reports set out an underlying philosophy
for prescribing, recording and reporting radiotherapy,
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gray-level histograms, cooccurrence matrices, 
and run-length matrices) with a sliding-
window approach, and on the Fisher Linear 
Discriminant Analysis classifier. 
 
 
      
 
Figure 2. Semiautomatic GTV delineation: 
preprocessing and CAD training. 
 
 
 
 
 
 
Figure 3. Semiautomatic GTV delineation: 
Segmentation and post-processing. 
 
 
After training, the ability to locate and contour 
the lesions in a new (validation) set of images 
is verified. Hence, a preprocessing step 
followed by a training step is needed. In first 
place (Fig. 2), the CT images are affine co-
registered to the corresponding T1-gad, then 
the transformation matrices are used to 
project the GTV drawn by the radiation 
oncologist onto the T1-gad images. Co-
registrations were performed by elastix 
(http://elastix.isi.uu.nl) [7,8]. After co-
registration, the T1-gad series with the co-
registered GTV was resliced to have 
homogeneous voxel size in the data set, and 
was then used to train GlioCAD to recognize 
and segment the tumor regions in T1-gad. 
During the segmentation and post-processing 
phases (Fig. 3), the trained CAD detects 
possible neoplastic regions in the T1-gad 
images of the validation set, reducing false 
positives through a mask obtained from the 
FLAIR image by thresholding and 
morphological operations. An active contour 
model merges the found regions into a single 
ROI, smoothing borders and solving 
inhomogeneity problems. The final identified 
ROI is used as the (computer-calculated) GTV. 
Accuracy quantification is given by the Jaccard 
coefficient, which compares the result with 
the manually defined GTV. 
The extension to the CTV will be performed by 
using again the mask obtained from the FLAIR 
image, and by considering a 2-cm border 
added to the GTV by morphological dilation. 
Finally, a descalping mask automatically 
obtained from the T1-gad images will be 
applied to further reduce false positives. 
Results 
Segmentation and accuracy assessment were 
carried out with Leave One Patient Out (LOPO) 
Cross Validation: the CAD system was applied 
in turn to each patient scan (Fig. 3), after 
training on the remaining patients (Fig. 2). In 
all cases, the CAD outlined the tumor 
structure with good accuracy. A post-
processing step was needed to reject some 
false positives and to make the identified 
volumes compliant with radiotherapy 
treatment requirements, with an acceptable 
hypothesis for the final GTV estimation 
(Fig. 4). Most of post-processing is automatic, 
with some manual interventions for 
verification and refinement. The mean Jaccard 
coefficient with its standard deviation was 
J=0.73±0.08, while the Dice coefficient was 
0.83±0.09. 
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Figure 4. CAD GTV segmentation examples. 
 
Discussion 
(Semi)automatic segmentation out of glioma 
imaging has been the subject of a large 
number of papers  [9–13], while less 
contributions specifically address RT 
applications and GTV contouring [14–20]. 
Among the latter, only few papers ([14,16] 
report quantitative accuracy data, which we 
can compare with our results.  
In [14] the effectiveness of knowledge-guided 
(KG) and supervised k-Nearest Neighbors 
(kNN) segmentation for delineating the GTV 
from glioma MR images are compared. The 
average accuracy of the kNN approach was 
56%±6% for 11 cases, whereas that of the KG 
was 52%±7% for 7 of the 11 cases, compared 
with the manual contouring. The kNN method 
lead to more robust segmentation results in 
all patients. The ground truth for accuracy 
assessment was obtained by multiple 
contours drawn by three physicians, and the 
probability that a given pixel is properly 
classified as part of the tumor (its “weight”) 
was determined by the number of times that 
this pixel was included in the outlines 
prepared by the physicians. Accuracy for the 
computer segmentation is the ratio of the 
total sum of weights contained within the 
computer segmentation volume to the total 
weights generated from the volumes 
produced by the physicians. This measure is a 
kind of probabilistic true-positive rate (i.e. 
sensitivity). Observing that by definition the 
Jaccard coefficient is always lower than or 
equal to sensitivity, our method clearly 
outperforms their results.  
Ref. [16] proposed a method for semi-
automated GTV segmentation of GB out of 
MR images for RT planning. Three-
dimensional (3D) MR images of 28 GB cases 
were used. First, a spherical volume of interest 
(VOI) including the GB was interactively 
defined. Then, the VOI was transformed to a 
two-dimensional (2D) image by a spiral-
scanning technique. Active contour models 
were used to delineate an optimal outline of 
the GB in the transformed 2D image. After 
inverse transform to the 3D space, a 
morphological filter was applied to smooth 
the shape of the 3D segmented region. The 
computer output was compared with the 
manually segmented regions by the Jaccard 
similarity coefficient (JSC) and the True 
Segmentation Coefficient (TSC), giving on 
average 74.2±9.8% and 84.1±7.1%, 
respectively. This paper is written in Japanese, 
making difficult a detailed comparison, but 
our results are similar in terms of Jaccard 
coefficient. 
Conclusions 
Although the proposed method is still under 
development and not fully automatic, 
nonetheless it is promising. It is currently 
under test on larger sets of images, and our 
aim is to increase accuracy while making the 
procedure as automatic as possible. The 
following step will be the complete CTV/PTV 
automatic delineation process. Together with 
the use of automatic or semiautomatic 
systems for OAR delineation [21–23], the 
procedure may be helpful in optimizing RT 
planning in patients affected by GB, in order 
to achieve standardization in contouring, thus 
reducing the operator-dependent variability. 
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